Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Müschen

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Gastroenterology|February 25, 1999
Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulationM Müschen, U Warskulat, T Peters-Regehr, et al.
Oncogene|October 6, 2005
BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cellsF Klein, N Feldhahn, S Herzog, et al.
Leukemia|November 25, 2010
ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1M Thai, P Y Ting, J McLaughlin, et al.
Transplantation|November 3, 1998
Fas ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and toleranceR Josien, M Müschen, E Gilbert, et al.
Cancer Research|November 4, 2000
Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cellsM Müschen, D Re, A Bräuninger, et al.
International Journal of Cancer|April 6, 2001
Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 geneM Müschen, D Re, B Betz, et al.
Cancer Research|March 31, 2001
Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cellsD Re, M Müschen, T Ahmadi, et al.
International Journal of Cancer|February 6, 1999
Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatinC Moers, U Warskulat, M Müschen, et al.
The Journal of Experimental Medicine|January 19, 2000
Rare occurrence of classical Hodgkin's disease as a T cell lymphomaM Müschen, K Rajewsky, A Bräuninger, et al.
Oncogene|March 29, 2006
The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cellsM Sprangers, N Feldhahn, S Herzog, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Gastroenterology|February 25, 1999
Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulationM Müschen, U Warskulat, T Peters-Regehr, et al.
Oncogene|October 6, 2005
BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cellsF Klein, N Feldhahn, S Herzog, et al.
Leukemia|November 25, 2010
ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1M Thai, P Y Ting, J McLaughlin, et al.
Transplantation|November 3, 1998
Fas ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and toleranceR Josien, M Müschen, E Gilbert, et al.
Cancer Research|November 4, 2000
Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cellsM Müschen, D Re, A Bräuninger, et al.
International Journal of Cancer|April 6, 2001
Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 geneM Müschen, D Re, B Betz, et al.
Cancer Research|March 31, 2001
Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cellsD Re, M Müschen, T Ahmadi, et al.
International Journal of Cancer|February 6, 1999
Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatinC Moers, U Warskulat, M Müschen, et al.
The Journal of Experimental Medicine|January 19, 2000
Rare occurrence of classical Hodgkin's disease as a T cell lymphomaM Müschen, K Rajewsky, A Bräuninger, et al.
Oncogene|March 29, 2006
The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cellsM Sprangers, N Feldhahn, S Herzog, et al.
Pageof 3